Current Treatment Approaches to HCC with a Special Consideration to Transplantation
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The mainstay of treatment of HCC has been both resectional and transplantation surgery. It is well known that, in selected, optimized patients, hepatectomy for HCC may be an option, even in patients with underlying...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2016/7926264 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551681699610624 |
|---|---|
| author | N. Bhardwaj M. T. P. R. Perera M. A. Silva |
| author_facet | N. Bhardwaj M. T. P. R. Perera M. A. Silva |
| author_sort | N. Bhardwaj |
| collection | DOAJ |
| description | Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The mainstay of treatment of HCC has been both resectional and transplantation surgery. It is well known that, in selected, optimized patients, hepatectomy for HCC may be an option, even in patients with underlying cirrhosis. Resectable patients with early HCC and underlying liver disease are however increasingly being considered for transplantation because of potential for better disease-free survival and resolution of underlying liver disease, although this approach is limited by the availability of donor livers, especially in resectable patients. Outcomes following liver transplantation improved dramatically for patients with HCC following the implementation of the Milan criteria in the late 1990s. Ever since, the rather restrictive nature of the Milan criteria has been challenged with good outcomes. There has also been an increase in the donor pool with marginal donors including organs retrieved following cardiac death being used. Even so, patients still continue to die while waiting for a liver transplant. In order to reduce this attrition, bridging techniques and methods for downstaging disease have evolved. Additionally new techniques for organ preservation have increased the prospect of this potentially curative procedure being available for a greater number of patients. |
| format | Article |
| id | doaj-art-7e2c2bcf142e45efa9d5d73f22cbe122 |
| institution | Kabale University |
| issn | 2090-0007 2090-0015 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Transplantation |
| spelling | doaj-art-7e2c2bcf142e45efa9d5d73f22cbe1222025-02-03T06:00:51ZengWileyJournal of Transplantation2090-00072090-00152016-01-01201610.1155/2016/79262647926264Current Treatment Approaches to HCC with a Special Consideration to TransplantationN. Bhardwaj0M. T. P. R. Perera1M. A. Silva2Department of Hepatobiliary and Pancreatic Surgery, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 7LE, UKThe Liver Unit, University Hospital Birmingham NHS Foundation Trust-Queen Elizabeth, Birmingham 15 2TH, UKDepartment of Hepatobiliary and Pancreatic Surgery, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 7LE, UKHepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The mainstay of treatment of HCC has been both resectional and transplantation surgery. It is well known that, in selected, optimized patients, hepatectomy for HCC may be an option, even in patients with underlying cirrhosis. Resectable patients with early HCC and underlying liver disease are however increasingly being considered for transplantation because of potential for better disease-free survival and resolution of underlying liver disease, although this approach is limited by the availability of donor livers, especially in resectable patients. Outcomes following liver transplantation improved dramatically for patients with HCC following the implementation of the Milan criteria in the late 1990s. Ever since, the rather restrictive nature of the Milan criteria has been challenged with good outcomes. There has also been an increase in the donor pool with marginal donors including organs retrieved following cardiac death being used. Even so, patients still continue to die while waiting for a liver transplant. In order to reduce this attrition, bridging techniques and methods for downstaging disease have evolved. Additionally new techniques for organ preservation have increased the prospect of this potentially curative procedure being available for a greater number of patients.http://dx.doi.org/10.1155/2016/7926264 |
| spellingShingle | N. Bhardwaj M. T. P. R. Perera M. A. Silva Current Treatment Approaches to HCC with a Special Consideration to Transplantation Journal of Transplantation |
| title | Current Treatment Approaches to HCC with a Special Consideration to Transplantation |
| title_full | Current Treatment Approaches to HCC with a Special Consideration to Transplantation |
| title_fullStr | Current Treatment Approaches to HCC with a Special Consideration to Transplantation |
| title_full_unstemmed | Current Treatment Approaches to HCC with a Special Consideration to Transplantation |
| title_short | Current Treatment Approaches to HCC with a Special Consideration to Transplantation |
| title_sort | current treatment approaches to hcc with a special consideration to transplantation |
| url | http://dx.doi.org/10.1155/2016/7926264 |
| work_keys_str_mv | AT nbhardwaj currenttreatmentapproachestohccwithaspecialconsiderationtotransplantation AT mtprperera currenttreatmentapproachestohccwithaspecialconsiderationtotransplantation AT masilva currenttreatmentapproachestohccwithaspecialconsiderationtotransplantation |